| Structure |
Chemical Name |
CAS |
MF |
 |
3-(3-TRIFLUOROMETHYL-PHENYL)-PROPYLAMINE |
104774-87-0 |
C10H12F3N |
 |
Vildagliptin Impurity 25 |
1563006-28-9 |
C7H10N2O2 |
 |
セルトラリンケトン |
124379-29-9 |
C16H12Cl2O |
 |
(4-(2-(アゼパン-1-イル)エトキシ)フェニル)メタノール |
223251-16-9 |
C15H23NO2 |
 |
(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
872980-38-6 |
C28H31ClO10 |
 |
4-ヒドロキシプロポホール |
1988-10-9 |
C12H18O2 |
 |
Vinorelbine Impurity DX |
89368-94-5 |
C46H55BrN4O8 |
 |
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid |
220352-36-3 |
C10H8F2O2 |
 |
1-hydroxypropan-2-yl 2-(2-(4-((4-chlorophenyl)(phenyl)
methyl)piperazin-1-yl)ethoxy)acetate compound with 2-
hydroxypropyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)
piperazin-1-yl)ethoxy)acetate (1:1) hydrochloride |
|
|
 |
N1-Methylbenzene-1,2,4-triaMine |
60651-29-8 |
C7H11N3 |
|
|
Dapoxetine Impurity 17 |
|
|
|
|
RocuroniuMbroMide iMpurity H |
|
|
 |
5-chloro-1-(3-diMethylaMinopropyl)-1-(4-fluorophenyl)-phthalan |
64169-45-5 |
C19H21ClFNO |
|
|
dextroMethorphanone |
|
|
 |
oxiracetaM related substance ISF3886 |
120428-80-0 |
C8H13N3O4 |
 |
Carvedilol IMpurity D |
1391052-16-6 |
C39H39N3O6 |
 |
DL-2-(4-Carboxyphenyl)propionic Acid |
67381-50-4 |
C10H10O4 |
 |
ベタメタゾン17-プロピオン酸21-メシル酸 |
15423-80-0 |
C26H35FO8S |
 |
12-O-メチルクラリスロマイシン |
128940-83-0 |
C39H71NO13 |
 |
3(R)-Hydroperoxy Simvastatin |
1092716-42-1 |
C25H38O7 |
 |
10-デアセチル-10-オキソバッカチンV |
151636-94-1 |
C29H34O10 |
 |
ドキシルアミン4-ピリジニル異性體 |
873407-01-3 |
C17H22N2O |
 |
Clopidogrel EP IMpurity D |
1421283-60-4 |
C24H21Cl2NO4S |
 |
Loratadine IMpurity E |
|
C22H23ClN2O2 |
|
|
Flucloxacillin IMpurity G |
|
|
 |
Gefitinib N-Oxide |
847949-51-3 |
C22H24ClFN4O4 |
 |
Milrinone IMpurity 3 |
98293-81-3 |
C12H7N3O3 |
 |
Nicardipine Related CoMpound 4 |
123973-71-7 |
C25H27N3O6 |
|
|
PraMipexole IMp.BI-II786BS |
|
|
|
|
Propofol IMpurity E |
|
|
|
|
Solifenacin Related CoMpound 5 |
|
|
 |
TelMisartan BroMo Ethyl Ester |
133085-87-7 |
C16H15BrO2 |
 |
Tolterodine Lactol IMpurity |
209747-04-6 |
C16H16O2 |
|
|
Valsartan N1-Trityl IMpurity |
|
|
 |
(3-Carbamoylallyl)trimethylammonium |
857162-57-3 |
C7H15N2O+ |
 |
N-(3-クロロ-4-ヒドロキシフェニル)アセトアミド |
3964-54-3 |
C8H8ClNO2 |
 |
ent-14S-3-Methoxy-17-MethylMorphinan |
1453167-99-1 |
C18H25NO |
 |
PD 224378 |
501665-88-9 |
C20H35NO11 |
 |
(rac,syn)-4-Deschloro-sertraline |
871838-58-3 |
C17H18ClN |
![1-[2-(DiMethylaMino)-1-phenylethyl]cyclohexanol](/CAS/20150408/GIF/93413-86-6.gif) |
1-[2-(DiMethylaMino)-1-phenylethyl]cyclohexanol |
93413-86-6 |
C16H25NO |
![1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol](/CAS/20150408/GIF/82961-02-2.gif) |
1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol |
82961-02-2 |
C15H23NO3 |
 |
11-Desethyl Irinotecan |
103816-16-6 |
C31H34N4O6 |
![7-[[[(CyanoMethyl)thio]acetyl]aMino]-7-Methoxy Cephalosporanic Acid](/CAS/GIF/56796-16-8.gif) |
7-[[[(CyanoMethyl)thio]acetyl]aMino]-7-Methoxy Cephalosporanic Acid |
56796-16-8 |
C15H17N3O7S2 |
 |
7S-Cefdinir |
178601-89-3 |
C14H13N5O5S2 |
 |
Dehydroxy BroMocelecoxib |
170570-75-9 |
C17H13BrF3N3O2S |
 |
Desethylene Norfloxacin Hydrochloride |
75001-77-3 |
C14H16FN3O3 |
 |
p-(2,3-Epoxypropoxy)benzyl Alcohol |
4204-78-8 |
C10H12O3 |
 |
α-Etoposide |
100007-53-2 |
C29H32O13 |
 |
N-Desmethyl-N-benzyl Sildenafil |
1446089-82-2 |
C28H34N6O4S |
 |
4-Hydroxy AtoMoxetine Oxalate |
457634-21-8 |
C19H23NO6 |
 |
1-エチル-4-オキソ-6-クロロ-7-(1-ピペラジニル)-1,4-ジヒドロ-3-キノリンカルボン酸 |
67681-84-9 |
C16H18ClN3O3 |
 |
Desfluoro flurbiprofen axetil |
1685278-08-3 |
C19H20O4 |
 |
Desloratadine IMpurity 6 |
38092-90-9 |
C20H21ClN2 |
|
|
ErtapeneM Ring Open IMpurity |
|
|
 |
DEXTROMETHORPHAN N-OXIDE |
1177494-18-6 |
C18H25NO2 |
![1-[(2-CHLOROPHENYL)DIPHENYLMETHYL]-1H-PYRAZOLE](/StructureFile/ChemBookStructure20/GIF/CB5646412.gif) |
1-[(2-CHLOROPHENYL)DIPHENYLMETHYL]-1H-PYRAZOLE |
|
C22H17ClN2 |
 |
Celecoxib Impurity 2 |
948293-46-7 |
C11H9F3N2 |
 |
1-METHYL-4-PHENYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-AMINE |
63156-74-1 |
C11H10F3N3 |
 |
2-(3-メトキシフェノキシ)エタンアミン |
6487-86-1 |
C9H13NO2 |
|
|
Sugammadex sodium Impurity 45 |
|
|
|
|
Carboprost Trometamol 1 |
|
|
 |
Tenofovir Impurity 113 |
1335287-28-9 |
C11H13IN4O |
|
|
Cefazolin USP Impurity L-δ3 |
|
|
|
|
Cabozantinib impurity 38 |
|
|
|
|
Cabozantinib impurity 57 |
|
|
|
|
(2R,3S)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol hydrochloride |
|
|
 |
(R)-2-((2R,5R)-3,6-dioxo-5-phenylpiperazin-2-yl)-5-methyl-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
860011-30-9 |
C16H17N3O4S |
|
|
Dapoxetine impurity 54 |
|
|
|
|
Doxofylline Impurity 21 |
|
|
|
|
LincoMycin iMpurity C |
|
|
|
|
Norfloxacin iMpurity E |
|
|
|
|
Posaconazole iMpurity 2 |
|
|
![Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol]](/CAS/20200611/GIF/2206135-50-2.gif) |
Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol] |
2206135-50-2 |
C25H18N2S2 |
|
|
Rabeprazole iMpurity (Chloro interMediate) |
|
|
 |
TaMsulosin IMpurity F |
|
C20H28N2O5S |
 |
TiaMulin IMpurity E (TiaMulone,11-Oxo TiaMulin) |
113323-39-0 |
C28H45NO4S |
![2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol](/CAS/20150408/GIF/848814-27-7.gif) |
2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol |
848814-27-7 |
C21H27N3O3S |
![(3AR,7R,7AR)-2,2-ジエチル-3A,6,7,7A-テトラヒドロ-7-[(メチルスルホニル)オキシ]-1,3-ベンゾジオキソール-5-カルボン酸エチルエステル](/CAS/20150408/GIF/204254-90-0.gif) |
(3AR,7R,7AR)-2,2-ジエチル-3A,6,7,7A-テトラヒドロ-7-[(メチルスルホニル)オキシ]-1,3-ベンゾジオキソール-5-カルボン酸エチルエステル |
204254-90-0 |
C15H24O7S |
 |
TorseMide Carboxylic Acid |
113844-99-8 |
C16H18N4O5S |
 |
(6-BroMo-2-ethyl-3-benzofuranyl)(3,5-dibroMo-4-hydroxyphenyl)Methanone |
1402819-05-9 |
C17H11Br3O3 |
![5'-broMo-[2,3'-bipyridin]-6'(1'H)-one](/CAS/20150408/GIF/381233-79-0.gif) |
5'-broMo-[2,3'-bipyridin]-6'(1'H)-one |
381233-79-0 |
C10H7BrN2O |
 |
1-((2R,3R)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one |
2243786-01-6 |
C30H35N5O3 |
 |
5-(3-fluorophenyl)-1H-pyrrole-3-carbaldehyde |
|
C11H8FNO |
 |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid bis(1-methylethyl) ester |
21881-78-7 |
C21H26N2O6 |
 |
4-メチルベンゼンスルホン酸2-ヒドロキシエチル |
42772-85-0 |
C9H12O4S |
![2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-](/CAS/20200611/GIF/1564265-94-6.gif) |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-94-6 |
C18H25N3O2 |
|
|
EMpagliflozin iMpurity 8 |
|
|
 |
EMpagliflozin iMpurity 13 |
2125472-55-9 |
C23H25ClO8 |
 |
6-Methyldi(ondansetron-3-de(1,2-diMethyl-1H-iMidazole)) |
1365727-07-6 |
C27H26N2O2 |
 |
Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione) |
910299-74-0 |
C19H24O4 |
 |
Etoricoxib Impurity 12 |
646459-41-8 |
C21H16ClN3O2S |
 |
Levofloxacin Tetrafluoro Impurity 2 |
103995-33-1 |
C14H12F4O4 |
 |
Mupirocin Impurity C |
|
C26H44O9 |
![2-(3,4-ジメトキシフェニル)-2-エチル-5-[メチル[2-(3,4-ジメトキシフェニル)エチル]アミノ]-ペンタンニトリル](/CAS/20180703/GIF/67018-83-1.gif) |
2-(3,4-ジメトキシフェニル)-2-エチル-5-[メチル[2-(3,4-ジメトキシフェニル)エチル]アミノ]-ペンタンニトリル |
67018-83-1 |
C26H36N2O4 |
 |
Warfarin Impurity 1 |
55901-61-6 |
C13H14O |
 |
Macitentan impurity B |
441796-13-0 |
C18H18Br2N6O4S |
|
|
Meropenem IMP B |
|
|
 |
4-(6-ブロモピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル |
412348-27-7 |
C14H20BrN3O2 |
![(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid](/CAS/20180703/GIF/1012341-56-8.gif) |
(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-56-8 |
C23H29NO4 |
 |
Linagliptin Impurity D |
666816-91-7 |
C20H28N6O4 |